Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe patent portfolio — 90 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
25
Drugs
509
Patents
90
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

United Therapeutics Europe patents

90 pharmaceutical patents indexed for United Therapeutics Europe. 5 expire within 24 months.

United Therapeutics Europe has 90 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 5 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

90 patents

Patent portfolio

Page 2 of 2

  1. US 9156786

    Process to prepare treprostinil, the active ingredient in remodulin®

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9114151

    Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8785421

    Use of vitamin D in dairy mastitis treatment

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8765813

    Use of treprostinil to treat and prevent ischemic lesions

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8748657

    Process to prepare treprostinil

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8716315

    Analogs of thalidomide as potential angiogenesis inhibitors

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8658694

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8653137

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8563614

    Use of treprostinil to treat neuropathic diabetic foot ulcers

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8497393

    Process to prepare treprostinil, the active ingredient in Remodulin®

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8455437

    Method to predict and prevent oxygen-induced inflammatory tissue injury

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8410169

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8350079

    Treprostinil formulation

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8349892

    Solid formulations of prostacyclin analogs

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8242305

    Process to prepare treprostinil, the active ingredient in remodulin

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8182842

    Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8163309

    Starch foam microparticles

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8003629

    21-substituted progesterone derivatives as new antiprogestational agents

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7999007

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7973057

    Thalidomide analogs

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7923535

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7879909

    Use of Treprostinil to treat neuropathic diabetic foot ulcers

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7875262

    Aqueous starch-oil dispersions having improved UV stability and absorbing ability

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7759330

    21-substituted progesterone derivatives as new antiprogestational agents

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7547712

    Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7541139

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7417070

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7361664

    Vitamin D receptor antagonists and related compositions and methods of use

    Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7320991

    Analogs of thalidomide as potential angiogenesis inhibitors

    Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7199157

    Use of treprostinil to improve kidney functions

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7122624

    Parathyroid hormone receptor ligands

    Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7087591

    21-substituted progesterone derivatives as new antiprogestational agents

    Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 6979724

    Calcium channel proteins

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6977272

    Method for antagonizing inhibition effects of alcohol on cell adhesion

    Expires Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6933277

    Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides

    Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6861415

    21-substituted progesterone derivatives as new antiprogestational agents

    Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6669962

    Starch microcapsules for delivery of active agents

    Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6441156

    Calcium channel compositions and methods of use thereof

    Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6328959

    Intestinal hydrogen removal using hydrogen-metabolizing microbes

    Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6238677

    Starch microcapsules for delivery of active agents

    Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6057346

    Inhibition of retroviral LTR promoters by calcium response modifiers

    Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does United Therapeutics Europe have?

90 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

5 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.